Biogen to invest $2 billion to expand manufacturing capability in North Carolina
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025
The new Zigly center features and offers comprehensive veterinary services
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Godavari Biorefineries receives patent from CNIPA
Subscribe To Our Newsletter & Stay Updated